Some studies have indicated that inhibition of autophagy with chloroquine (CQ) enhanced the effect of erlotinib treatment in EGFR-mutated, but not in wild-type NSCLC cells 39. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.